11th International Conference on Hematology & Hematological Oncology November 08-09, 2017 Las Vegas, Nevada, USA

James Granfortuna MD FACP graduated from Mount Sinai School of Medicine in 1980 and completed a Hematology Oncology Fellowship at the State University of NY Health Sciences Center in Syracuse NY in 1987. He is board certified in both specialties. He is currently an Associate Professor of Clinical Medicine at the Cone Health Internal Medicine Teaching Program in Greensboro, NC

Internal Medicine, Hematology

Knox Van Dyke is a Professor of Biochemistry and Molecular Pharmacology at West Virginia University Medical School with 50 years of research experience. He completed his PhD in Biochemistry in the Edward A Doisy–Nobel Prize Department at Saint Louis University in 1966. He did Post-doctoral studies in the Department of Pharmacology at West Virginia University. During this time, he developed the first effective drug screening system for antimalarial drugs while screening over 10,000 drugs. Mefloquine and halofantrine were recognized by this screening system and were further developed by Walter Reed and various companies as patented drugs. He first solved the problem of black lung disease and silicosis by demonstrating that coal dust per se is not particularly toxic to human cells compared to silica and that silica is not particularly toxic alone but it is contaminated with calcium. He recognized that urate in the blood protects against peroxynitrite generating chronic diseases. He has recognized that many chronic diseases like cancer, arthritis, diabetes and heart diseases etc., are caused by excessive peoxynitrite or its derivatives. He has over 300 publications and 150 patents.

Diabetes, Oncology

David W. Scott, Ph.D. is Vice Chair for Research, Department of Medicine, Uniformed Services School of Health Sciences, Bethesda, MD. An alumnus of Antioch College, University of Chicago (MS) and Yale (PhD). Following a fellowship at Oxford University, he held tenured positions at Duke University, University of Rochester, and University of Maryland Medical School. Dr. Scott has contributed to over 200 research papers on immunologic tolerance, and its application in autoimmune diseases, hemophilia and gene therapy. The author of two textbooks, including The Nature of Immunologic Tolerance, he ia recipient of a number of awards, e.g. Distinguished Service Award from the American Association of Immunologists, a Boarhaave Professorship at Leiden University in Holland, and the 2009 Scientific Achievement Award from AAPS.

Autoimmune diseases, Hemophilia and gene therapy